✦ LIBER ✦

The Costs and Efficacy of Liposomal Doxorubicin in Platinum-Refractory Ovarian Cancer in Heavily Pretreated Patients

✍ Scribed by Martee L. Hensley; Brad Hoppe; Larry Leon; Paul Sabbatini; Carol Aghajanian; Dennis Chi; David R. Spriggs

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of metronomic non-pe

✍ L. Manso, N. Valdiviezo, J. Sepúlveda, E. Ciruelos… 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 158 KB

Gemcitabine and pegylated liposomal doxo

✍ Dimitrios Pectasides; Nicolaos Xiros; George Papaxoinis; Gerasimos Aravantinos; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Evaluation of Pegylated Liposomal Doxoru

✍ Hao Lin; Chih-Wen Tseng; Hung-Yaw Chang; Hsien-Ming Lu; Yu-Che Ou; Chan-Chao Cha 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Carboplatin/gemcitabine alternating with

✍ D. Pectasides; E. Pectasides; G. Papaxoinis; A. Psyrri; K. Pliarchopoulou; A. Ko 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Effects of bevacizumab and pegylated lip

✍ Kazuya Kudoh; Masashi Takano; Hiroko Kouta; Ryoko Kikuchi; Tsunekazu Kita; Morik 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Phase 2 study of canfosfamide in combina

✍ John J Kavanagh; Charles F Levenback; Pedro T Ramirez; Judith L Wolf; Carla L Mo 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 404 KB